/ /

  • linkedin
  • Increase Font
  • Sharebar

    Microstent approval makes big news in glaucoma world


    Complications occurred in 39.3% of patients in the device group and 35.9% in the cataract surgery group, according to the FDA.

    Alcon acquired Transcend Medical, developer of the micro-stent, in February 2016.


    More articles: 

    Visit the Glaucoma 360 homepage!

    Techniques for treating narrow angle glaucoma

    How nutrition, yoga, and acupuncture affect glaucoma

    Glaucoma ‘tsunami’ bearing down on how EyeMDs will practice medicine

    What are ophthalmologists reading this summer? 

    Want More Cutting-Edge Advancements? Subscribe Here For Free eNewsletter


    Jolie Higazi
    Jolie is the Content Specialist for Ophthalmology Times. She can be reached at [email protected]

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results